Published in Tissue Antigens on October 01, 2000
HLA-DQ1 associated with reflex sympathetic dystrophy. Neurology (1999) 1.50
Prognostic significance of a new histologic grading system for canine osteosarcoma. Vet Pathol (2002) 1.10
The absence of DR51 in a DRB5-positive individual DR2ES is caused by a null allele (DRB5*0108N) Tissue Antigens (1997) 1.04
Histocompatibility antigens and other genetic markers in ankylosing spondylitis and inflammatory bowel diseases. J Immunogenet (1977) 1.01
Maternal-specific methylation of the human IGF2R gene is not accompanied by allele-specific transcription. Genomics (1996) 0.99
HLA-DRw4 in Felty's syndrome. Arthritis Rheum (1980) 0.97
Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants. Tissue Antigens (2009) 0.95
Comparison of DRB sequence-based typing using different strategies. Tissue Antigens (1997) 0.93
HLA-DP antibodies before and after renal transplantation. Tissue Antigens (2010) 0.91
Reanalysis of sequence-based HLA-A, -B and -Cw typings: how ambiguous is today's SBT typing tomorrow. Tissue Antigens (2007) 0.90
Localization of HLA on the short arm of chromosome 6. Hum Genet (1977) 0.89
HLA class II amino acid epitopes as susceptibility markers of sarcoidosis. Tissue Antigens (2007) 0.89
High-resolution HLA typing for the DQB1 gene by sequence-based typing. Tissue Antigens (1998) 0.87
Actin cytoskeletal lesions in differentiated human colon carcinoma Caco-2 cells after exposure to soybean agglutinin. Biol Cell (1989) 0.86
Increased incidence of HLA-DR2 in patients with pernicious anemia. Tissue Antigens (1982) 0.85
Luminex donor-specific crossmatches. Tissue Antigens (2008) 0.84
B*27 in molecular diagnostics: impact of new alleles and polymorphism outside exons 2 and 3. Tissue Antigens (2002) 0.84
Lobaplatin as an adjuvant chemotherapy to surgery in canine appendicular osteosarcoma: a phase II evaluation. Anticancer Res (2003) 0.83
Isolation of Mycobacterium mageritense from the lung of a harbor porpoise (Phocoena phocoena) with severe granulomatous lesions. J Wildl Dis (2008) 0.83
Tularaemia in a brown hare (Lepus europaeus) in 2013: first case in the Netherlands in 60 years. Euro Surveill (2013) 0.83
[No proof for usutuvirus as cause of death in songbirds in the Netherlands (fall 2012)]. Tijdschr Diergeneeskd (2014) 0.82
Detection of HLA class I and II antibodies by ELISA and complement-dependent cytotoxicity before and after transplantation. Transplantation (2000) 0.81
Sequence-based typing of HLA-DQA1: comprehensive approach showed molecular heterogeneity. Tissue Antigens (2007) 0.79
Donor-specific antibodies after transplantation by flow cytometry: relative change in fluorescence ratio most sensitive risk factor for graft survival. Transplantation (1998) 0.79
Human leukocyte antigen sensitization after cryopreserved human meniscal transplantations. Transplantation (1997) 0.79
A reliable and efficient high resolution typing method for HLA-C using sequence-based typing. Tissue Antigens (1998) 0.78
Allelic polymorphism in introns 1 and 2 of the HLA-DQA1 gene. Tissue Antigens (2005) 0.78
Strong association between HLA-Cw*0706 and HLA-B*44032 in the Bubi population from Equatorial Guinea. Tissue Antigens (2000) 0.78
Intron sequences of HLA-B*73. Tissue Antigens (2001) 0.78
Segregation of HLA haplotypes in 100 families with a myasthenia gravis patient. J Immunogenet (1977) 0.77
No advantage of flow cytometry crossmatch over complement-dependent cytotoxicity in immunologically well-documented renal allograft recipients. Transplantation (1996) 0.76
HLA-DR matched transfusions: development of donor-specific T- and B-cell antibodies and renal allograft outcome. Transplantation (1999) 0.76
Polymorphism of intron 4 in HLA-A, -B and -C genes. Tissue Antigens (2003) 0.76
Sequence-based typing of exons 1-5 of a new HLA-B allele, B*3927*. Tissue Antigens (2004) 0.75
Individual mice of one inbred strain produce anti-H-2 and anti-HLA antibodies of different specificities. Tissue Antigens (1978) 0.75
[Recurrent skin problems in a manatee: the diagnostic approach]. Tijdschr Diergeneeskd (2003) 0.75
Identification of a new HLA-C allele, Cw*0316, by sequence-based typing. Tissue Antigens (2004) 0.75
Presence of the DRB4*0103102N null allele in different DRB1*04-positive individuals. Tissue Antigens (2000) 0.75
Antigen PR - another allele of the HLA-B locus. Tissue Antigens (1979) 0.75
Identification of three new DRB1 alleles, DRB1*0107, *0425 and *13012 and confirmation of DRB4*01033. Tissue Antigens (2003) 0.75
Helper and cytotoxic T cell precursor frequencies are not predictive for development of acute graft-versus-host disease after partially T cell-depleted HLA-identical sibling BMT. Bone Marrow Transplant (1998) 0.75
Use of a bipolar vessel-sealing device in resection of canine insulinoma. J Small Anim Pract (2011) 0.75
There is more to HLA-C than exons 2 and 3: sequencing exons 1, 4 and 5. Tissue Antigens (1999) 0.75
Identification of two new HLA-A alleles, A*2419 and A*3011, by sequence-based typing. Tissue Antigens (2002) 0.75
Identification of two new HLA-B22 variants, HLA-B*5509 and B*5606. Tissue Antigens (2001) 0.75
Identification of a new DRB4 allele (DRB4*0105) by sequence-based typing. Tissue Antigens (1997) 0.75
Characterization of a new HLA-A allele, A*010103. Tissue Antigens (2006) 0.75
High-resolution HLA typing for the DRB3/4/5 genes by sequence-based typing. Tissue Antigens (1997) 0.75
Fine specificity of the alloantiserum MSD-51: epitope mapping of HLA-DRw53 determinants. Hum Immunol (1991) 0.75
Identification of a new DRB3*02 allele (DRB3*0207) by sequence-based typing. Tissue Antigens (1997) 0.75
Molecular and serological identification of the HLA-A*3404 allele. Tissue Antigens (2002) 0.75
High resolution HLA-DRB1 SSP typing for cadaveric donor transplantation. Tissue Antigens (1995) 0.75
Identification of the new HLA-DRB1*0812 allele detected by sequenced based typing. Immunogenetics (1996) 0.75
Sequence-based typing of HLA-B: the B7 cross-reacting group. Tissue Antigens (2000) 0.75
Blood vitamin D(3) metabolite concentrations of adult female bearded dragons (Pogona vitticeps) remain stable after ceasing UVb exposure. Comp Biochem Physiol B Biochem Mol Biol (2013) 0.75
Identification of a new HLA-B*40 variant, B*4035. Tissue Antigens (2003) 0.75
Ambiguities of human leukocyte antigen-B resolved by sequence-based typing of exons 1, 4, and 5. Tissue Antigens (2004) 0.75
Identification of the new HLA-DRB1*0812 allele detected by sequencing based typing. Immunogenetics (1996) 0.75
Identification of the new allele B*3556 and extension of the sequences of B*4420 and B*4427. Tissue Antigens (2006) 0.75
Identification of a new HLA-DRB1*13 allele (DRB1*1326) with a short DRB1*16 sequence. Tissue Antigens (1997) 0.75
Identification of HLA-A*0249 and confirmation of A*2615. Tissue Antigens (2002) 0.75
Two new HLA DPB1 alleles identified by sequence-based typing: DPB1*8201 and DPB1*8301. Tissue Antigens (2000) 0.75
A novel HLA-A*11 allele, A*1118, identified by sequence-based typing. Tissue Antigens (2006) 0.75
Sequence analysis of exons 1, 2, 3, 4 and 5 of the HLA-B5/35 cross-reacting group. Tissue Antigens (2002) 0.75